61 results
S-3ASR
EX-1.2
BEAM
Beam Therapeutics Inc
27 Feb 24
Automatic shelf registration
6:10pm
described in, the Registration Statement and the Prospectus), short-term debt or long-term debt of the Company or its subsidiaries, or any dividend … or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award under Nasdaq rules or other compensation plan of the Company
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
with a single dose significantly improved long-term survival in GSD1a mouse model Preclinical studies of BEAM-301 demonstrated a single dose significantly … improved long-term survival out to a year in humanized R83C homozygous mice Untreated homozygous R83C mice die within weeks of birth Given its rare
8-K
EX-99.2
xc80g
8 Jan 24
Results of Operations and Financial Condition
6:55am
8-K
EX-99.1
hjkdartqs2rig 6q4
8 Nov 23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
trlgl
31 Oct 23
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
6:44am
8-K
EX-99.2
c147pgr
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
8-K
EX-99.1
68fvngihu3m36y4qv9a
10 May 23
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
7:00am
8-K
EX-99.1
k3cvv48 gnwvks4nbb4
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
y9wc ot4508q8r
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am